AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

POSACONAZOLE

5 registrations across 4 African markets— 5 active

Markets with POSACONAZOLE

🇿🇼Zimbabwe
2 registrations
2 active
🇷🇼Rwanda
1 registration
1 active
🇹🇿Tanzania
1 registration
1 active
🇿🇦South Africa
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
POSAREL
TABLET; ORAL
🇿🇼ZimbabwePHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTDactiveFeb 2031
POSACONAZOLE 100 COSPHARM
TABLET, COATED; ORAL
🇿🇼ZimbabweCOSPHARM INVESTMENTS PVT LTDactiveOct 2030
ASPOCAN
Tablets
🇷🇼RwandaM/s. Hetero Labs LimitedactiveAug 2029
NOXAFIL 40 mg/ml🇿🇦South AfricaMSD (Pty) LtdactiveJan 1900
ASPOCAN
Tablets
🇹🇿TanzaniaHetero Labs Limitedactive—

POSACONAZOLE in Africa — Regulatory Overview

POSACONAZOLE is registered across 4 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zimbabwe, Rwanda, Tanzania, South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 5 registrations, 5 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.